Efficacy and Safety of Epratuzumab in Moderately to Severely Active Systemic Lupus Erythematosus: results From Two Phase III Randomized, Double-Blind, Placebo-Controlled Trials

Clowse, Megan E. B.Wallace, DanielFurie, Richard A.Petri, Michelle A.Pike, Marilyn C.Leszczyński, PiotrNeuwelt, C. MichaelHobbs, KathrynKeiserman, MauroDuca, LilianaKalunian, Kenneth C.Galateanu, CatrinelBongardt, SabineStach, ChristianBeaudot, CarolynKilgallen, BrianGordon, CarolineSzűcs, Gabriella2018-03-122018-03-122017Arthritis & Rheumatology. - 69 : 2 (2017), p. 362-375. -Arthritis & Rheumatology. - 2326-51912326-5191http://hdl.handle.net/2437/248621Efficacy and Safety of Epratuzumab in Moderately to Severely Active Systemic Lupus Erythematosus: results From Two Phase III Randomized, Double-Blind, Placebo-Controlled Trialsfolyóiratcikkopen access articlehttp://webpac.lib.unideb.hu:8082/ebib/CorvinaWeb?action=cclfind&resultview=long&ccltext=idno+BIBFORM072674OrvostudományokKlinikai orvostudományokhttp://doi.wiley.com/10.1002/art.39856szerzőkWileyCC BY-NC 3.0http://dx.doi.org/10.1002/art.398562018-05-18